Mayank Cattle Food Ltd (544106)
Latest quarterly results (H2 FY26)
In its latest reported quarter, H2 FY26, Mayank Cattle's revenue was ₹218 Cr (+2.8% year on year, +17.8% on the previous half-year), and net profit ₹3.0 Cr (+0.0% year on year); the operating margin was 3.2%.
| H2 FY26 (₹ Cr) | Value | YoY vs H2 FY25 | vs prev. half |
|---|---|---|---|
| Revenue | ₹218 | +2.8% | +17.8% |
| Operating profit | ₹7.0 | +0.0% | +16.7% |
| Net profit | ₹3.0 | +0.0% | +0.0% |
| EPS (₹) | 6.46 | — | — |
| Operating margin | 3.2% | — | — |
No EPS growth against H1 FY26 and H2 FY25: 1:1 bonus in Aug 2026.
📢 Recent Corporate Announcements
Mayank Cattle Food Limited has allotted 54,00,000 fully paid-up bonus equity shares of face value Rs 10 each to eligible shareholders in a 1:1 ratio. The record date for determining eligible members was August 24, 2026. Following this allotment, the company's total paid-up equity share capital doubles to Rs 10.80 crore, comprising 1,08,00,000 equity shares.
- Allotted 54,00,000 bonus equity shares of face value Rs 10 each
- Bonus issue executed in the ratio of 1:1 (1 bonus share for every 1 existing share)
- Paid-up share capital increased from Rs 5.40 crore to Rs 10.80 crore
- Record date for allotment was August 24, 2026
Mayank Cattle Food Limited announced the launch of its new product, 'MAYANK UDDERSAFE', on August 24, 2026. The product is an udder health protection formula designed to prevent and manage mastitis in dairy cattle and buffaloes in the domestic market. Positioned as a forward integration step, the company aims to diversify income sources and enhance margins beyond standard cattle feed. Specific capex investments and revenue projections for the product were not disclosed in the filing.
- Launched 'MAYANK UDDERSAFE' on August 24, 2026, targeting the domestic animal healthcare and cattle feed segment
- Formulated as an advanced udder health protection solution to manage mastitis and reduce milk loss in cows and buffaloes
- Positions the company into forward-integrated, value-added animal healthcare products
- Commercial revenue targets and initial investment amounts were not disclosed
Mayank Cattle Food Ltd has received shareholder approval at its 28th Annual General Meeting to double its authorised share capital from ₹6 crore to ₹12 crore. This procedural amendment to the Memorandum of Association (Clause 5) allows the company to issue up to 1.2 crore equity shares of ₹10 each. While this does not result in immediate dilution, it creates the necessary headroom for future fundraising, bonus issues, or stock-based acquisitions. The company currently operates with a TTM revenue of ₹794 crore and a net worth of ₹38 crore.
- Authorised share capital increased from ₹6,00,00,000 to ₹12,00,00,000.
- Total authorized equity shares now stand at 1,20,00,000 with a face value of ₹10 each.
- Approval was granted by shareholders via a Special Resolution at the 28th AGM on August 06, 2026.
- The amendment specifically alters the Capital Clause (Clause 5) of the Memorandum of Association.
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
